MicroRNAs in the stressed heart: Sorting the signal from the noise

Cells

Volumn 3, Issue 3, 2014, Pages 778-801

  Matkovich, Scot J ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Heart; Hypertrophy; MicroRNA; Ribosome; RNA induced silencing complex; Stress; Systems biology; Translation

Indexed keywords

MICRORNA; MICRORNA 122; MICRORNA 208; MICRORNA 21; MICRORNA 24; MICRORNA 34; RNA INDUCED SILENCING COMPLEX; TRANSCRIPTOME; UNCLASSIFIED DRUG;

CELL DIFFERENTIATION; CELL MATURATION; CELLULAR STRESS SIGNAL; CROSS LINKING; EXERCISE; GENETIC ALGORITHM; GENETIC ANALYSIS; HEART INFARCTION; HEART STRESS; HIGH THROUGHPUT SEQUENCING; HUMAN; HYPERTENSION; IMMUNOPRECIPITATION; MICROARRAY ANALYSIS; MRNA EXPRESSION ASSAY; NONHUMAN; NUCLEOTIDE SEQUENCE; REVIEW; SIGNAL TRANSDUCTION; TRANSLATION REGULATION;

EID: 84927695353     PISSN: None     EISSN: 20734409     Source Type: Journal    
DOI: 10.3390/cells3030778     Document Type: Review

References (106)

1. Fire, A.; Xu, S.; Montgomery, M.K.; Kostas, S.A.; Driver, S.E.; Mello, C.C. Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature 1998, 391, 806-811.
2. Winter, J.; Jung, S.; Keller, S.; Gregory, R.I.; Diederichs, S. Many roads to maturity: MicroRNA biogenesis pathways and their regulation. Nat. Cell Biol. 2009, 11, 228-234.
3. Yang, J.S.; Phillips, M.D.; Betel, D.; Mu, P.; Ventura, A.; Siepel, A.C.; Chen, K.C.; Lai, E.C. Widespread regulatory activity of vertebrate microRNA* species. RNA 2011, 17, 312-326.
4. Zhao, Y.; Ransom, J.F.; Li, A.; Vedantham, V.; Von Drehle, M.; Muth, A.N.; Tsuchihashi, T.; McManus, M.T.; Schwartz, R.J.; Srivastava, D. Dysregulation of cardiogenesis, cardiac conduction, and cell cycle in mice lacking miRNA-1-2. Cell 2007, 129, 303-317.
5. Liu, N.; Bezprozvannaya, S.; Williams, A.H.; Qi, X.; Richardson, J.A.; Bassel-Duby, R.; Olson, E.N. microRNA-133a regulates cardiomyocyte proliferation and suppresses smooth muscle gene expression in the heart. Genes Dev. 2008, 22, 3242-3254.
6. Da Costa Martins, P.A.; Salic, K.; Gladka, M.M.; Armand, A.S.; Leptidis, S.; El Azzouzi, H.; Hansen, A.; Coenen-de Roo, C.J.; Bierhuizen, M.F.; Van der Nagel, R.; et al. MicroRNA-199b targets the nuclear kinase Dyrk1a in an auto-amplification loop promoting calcineurin/NFAT signalling. Nat. Cell Biol. 2010, 12, 1220-1227.
7. Matkovich, S.J.; Hu, Y.; Eschenbacher, W.H.; Dorn, L.E.; Dorn, G.W., II. Direct and indirect involvement of microRNA-499 in clinical and experimental cardiomyopathy. Circ. Res. 2012, 111, 521-531.
8. Huang, Z.P.; Chen, J.; Seok, H.Y.; Zhang, Z.; Kataoka, M.; Hu, X.; Wang, D.Z. MicroRNA-22 regulates cardiac hypertrophy and remodeling in response to stress. Circ. Res. 2013, 112, 1234-1243.
9. Gurha, P.; Abreu-Goodger, C.; Wang, T.; Ramirez, M.O.; Drumond, A.L.; van Dongen, S.; Chen, Y.; Bartonicek, N.; Enright, A.J.; Lee, B.; et al. Targeted deletion of microRNA-22 promotes stress-induced cardiac dilation and contractile dysfunction. Circulation 2012, 125, 2751-2761.
10. Gladka, M.M.; da Costa Martins, P.A.; De Windt, L.J. Small changes can make a big difference-MicroRNA regulation of cardiac hypertrophy. J. Mol. Cell. Cardiol. 2012, 52, 74-82.
11. Kuppusamy, K.T.; Sperber, H.; Ruohola-Baker, H. MicroRNA regulation and role in stem cell maintenance, cardiac differentiation and hypertrophy. Curr. Mol. Med. 2013, 13, 757-764.
12. Ooi, J.Y.; Bernardo, B.C.; McMullen, J.R. The therapeutic potential of miRNAs regulated in settings of physiological cardiac hypertrophy. Future Med. Chem. 2014, 6, 205-222.
13. Fiedler, J.; Thum, T. MicroRNAs in myocardial infarction. Arterioscler. Thromb. Vasc. Biol. 2013, 33, 201-205.
14. Greco, S.; Gaetano, C.; Martelli, F. HypoxamiR regulation and function in ischemic cardiovascular diseases. Antioxid. Redox Signal. 2013. doi:10.1089/ars.2013.5403.
15. Topkara, V.K.; Mann, D.L. Role of microRNAs in cardiac remodeling and heart failure. Cardiovasc. Drugs Ther. 2011, 25, 171-182.
16. Dorn, I.I.; Gerald, W. MicroRNAs in cardiac disease. Transl. Res. 2011, 157, 226-235.
17. Melman, Y.F.; Shah, R.; Das, S. MicroRNAs in Heart Failure: Is the Picture Becoming Less miRky? Circ. Heart Fail. 2014, 7, 203-214.
18. Lusis, A.J.; Weiss, J.N. Cardiovascular networks: Systems-based approaches to cardiovascular disease. Circulation 2010, 121, 157-170.
19. Dewey, F.E.; Wheeler, M.T.; Ashley, E.A. Systems biology of heart failure, challenges and hopes. Curr. Opin. Cardiol. 2011, 26, 314-321.
20. Parikh, V.N.; Jin, R.C.; Rabello, S.; Gulbahce, N.; White, K.; Hale, A.; Cottrill, K.A.; Shaik, R.S.; Waxman, A.B.; Zhang, Y.Y.; et al. MicroRNA-21 integrates pathogenic signaling to control pulmonary hypertension: Results of a network bioinformatics approach. Circulation 2012, 125, 1520-1532.
21. Gerstein, M.B.; Kundaje, A.; Hariharan, M.; Landt, S.G.; Yan, K.K.; Cheng, C.; Mu, X.J.; Khurana, E.; Rozowsky, J.; Alexander, R.; et al. Architecture of the human regulatory network derived from ENCODE data. Nature 2012, 489, 91-100.
22. Judson, R.L.; Greve, T.S.; Parchem, R.J.; Blelloch, R. MicroRNA-based discovery of barriers to dedifferentiation of fibroblasts to pluripotent stem cells. Nat. Struct. Mol. Biol. 2013, 20, 1227-1235.
23. Kozomara, A.; Griffiths-Jones, S. miRBase: Integrating microRNA annotation and deep-sequencing data. Nucleic Acids Res. 2011, 39, D152-157.
24. Moore, M.J.; Zhang, C.; Gantman, E.C.; Mele, A.; Darnell, J.C.; Darnell, R.B. Mapping Argonaute and conventional RNA-binding protein interactions with RNA at single-nucleotide resolution using HITS-CLIP and CIMS analysis. Nat. Protoc. 2014, 9, 263-293.
25. Hafner, M.; Lianoglou, S.; Tuschl, T.; Betel, D. Genome-wide identification of miRNA targets by PAR-CLIP. Methods 2012, 58, 94-105.
26. Erhard, F.; Dolken, L.; Jaskiewicz, L.; Zimmer, R. PARma: Identification of microRNA target sites in AGO-PAR-CLIP data. Genome Biol. 2013, 14, R79.
27. Khorshid, M.; Hausser, J.; Zavolan, M.; van Nimwegen, E. A biophysical miRNA-mRNA interaction model infers canonical and noncanonical targets. Nat. Methods 2013, 10, 253-255.
28. Liu, C.; Mallick, B.; Long, D.; Rennie, W.A.; Wolenc, A.; Carmack, C.S.; Ding, Y. CLIP-based prediction of mammalian microRNA binding sites. Nucleic Acids Res. 2013, 41, e138.
29. Rennie, W.; Liu, C.; Carmack, C.S.; Wolenc, A.; Kanoria, S.; Lu, J.; Long, D.; Ding, Y. STarMir: A web server for prediction of microRNA binding sites. Nucleic Acids Res. W1 2014, W114-W118.
30. Care, A.; Catalucci, D.; Felicetti, F.; Bonci, D.; Addario, A.; Gallo, P.; Bang, M.L.; Segnalini, P.; Gu, Y.; Dalton, N.D.; et al. MicroRNA-133 controls cardiac hypertrophy. Nat. Med. 2007, 13, 613-618.
31. Van Rooij, E.; Quiat, D.; Johnson, B.A.; Sutherland, L.B.; Qi, X.; Richardson, J.A.; Kelm, R.J. Jr.; Olson, E.N. A family of microRNAs encoded by myosin genes governs myosin expression and muscle performance. Dev. Cell 2009, 17, 662-673.
32. Matkovich, S.J.; Wang, W.; Tu, Y.; Eschenbacher, W.H.; Dorn, L.E.; Condorelli, G.; Diwan, A.; Nerbonne, J.M.; Dorn, G.W. 2nd, MicroRNA-133a protects against myocardial fibrosis and modulates electrical repolarization without affecting hypertrophy in pressure-overloaded adult hearts. Circ. Res. 2010, 106, 166-175.
33. Patrick, D.M.; Montgomery, R.L.; Qi, X.; Obad, S.; Kauppinen, S.; Hill, J.A.; Van Rooij, E.; Olson, E.N. Stress-dependent cardiac remodeling occurs in the absence of microRNA-21 in mice. J. Clin. Invest. 2010, 120, 3912-3916.
34. Hu, Y.; Matkovich, S.J.; Hecker, P.A.; Zhang, Y.; Dorn, G.W., II. Epitranscriptional orchestration of genetic reprogramming is an emergent property of stress-regulated cardiac microRNAs. Proc. Natl. Acad. Sci. USA 2012, 109, 19864-19869.
35. Matkovich, S.J.; Hu, Y.; Dorn, G.W. Regulation of cardiac microRNAs by cardiac microRNAs. Circ. Res. 2013, 113, 62-71.
36. Mencia, A.; Modamio-Hoybjor, S.; Redshaw, N.; Morin, M.; Mayo-Merino, F.; Olavarrieta, L.; Aguirre, L.A.; del Castillo, I.; Steel, K.P.; Dalmay, T.; et al. Mutations in the seed region of human miR-96 are responsible for nonsyndromic progressive hearing loss. Nat. Genet. 2009, 41, 609-613.
37. Dorn, G.W., 2nd; Matkovich, S.J.; Eschenbacher, W.H.; Zhang, Y. A human 3′ miR-499 mutation alters cardiac mRNA targeting and function. Circ. Res. 2012, 110, 958-967.
38. Humphreys, D.T.; Hynes, C.J.; Patel, H.R.; Wei, G.H.; Cannon, L.; Fatkin, D.; Suter, C.M.; Clancy, J.L.; Preiss, T. Complexity of murine cardiomyocyte miRNA biogenesis, sequence variant expression and function. PLoS One 2012, 7, e30933.
39. Garcia, D.M.; Baek, D.; Shin, C.; Bell, G.W.; Grimson, A.; Bartel, D.P. Weak seed-pairing stability and high target-site abundance decrease the proficiency of lsy-6 and other microRNAs. Nat. Struct. Mol. Biol. 2011, 18, 1139-1146.
40. Grimson, A.; Farh, K.K.; Johnston, W.K.; Garrett-Engele, P.; Lim, L.P.; Bartel, D.P. MicroRNA targeting specificity in mammals: Determinants beyond seed pairing. Mol. Cell 2007, 27, 91-105.
41. Krek, A.; Grun, D.; Poy, M.N.; Wolf, R.; Rosenberg, L.; Epstein, E.J.; MacMenamin, P.; Da Piedade, I.; Gunsalus, K.C.; Stoffel, M.; et al. Combinatorial microRNA target predictions. Nat. Genet. 2005, 37, 495-500.
42. Wang, X.; El Naqa, I.M. Prediction of both conserved and nonconserved microRNA targets in animals. Bioinformatics 2008, 24, 325-332.
43. Wang, X. miRDB: A microRNA target prediction and functional annotation database with a wiki interface. RNA 2008, 14, 1012-1017.
44. Chi, S.W.; Hannon, G.J.; Darnell, R.B. An alternative mode of microRNA target recognition. Nat. Struct. Mol. Biol. 2012, 19, 321-327.
45. Hausser, J.; Syed, A.P.; Bilen, B.; Zavolan, M. Analysis of CDS-located miRNA target sites suggests that they can effectively inhibit translation. Genome Res. 2013, 23, 604-615.
46. Shin, C.; Nam, J.W.; Farh, K.K.; Chiang, H.R.; Shkumatava, A.; Bartel, D.P. Expanding the microRNA targeting code: Functional sites with centered pairing. Mol. Cell 2010, 38, 789-802.
47. Tsang, J.S.; Ebert, M.S.; van Oudenaarden, A. Genome-wide dissection of microRNA functions and cotargeting networks using gene set signatures. Mol. Cell 2010, 38, 140-153.
48. Matkovich, S.J.; Zhang, Y.; Van Booven, D.; Dorn, G.W. 2nd, Deep mRNA sequencing for in vivo functional analysis of cardiac transcriptional regulators. Application to Gαq. Circ. Res. 2010, 106, 1459-1467.
49. Baillat, D.; Shiekhattar, R. Functional dissection of the human TNRC6 (GW182-related) family of proteins. Mol. Cell. Biol. 2009, 29, 4144-4155.
50. Cambronne, X.A.; Shen, R.; Auer, P.L.; Goodman, R.H. Capturing microRNA targets using an RNA-induced silencing complex (RISC)-trap approach. Proc. Natl. Acad. Sci. USA 2012, 109, 20473-20478.
51. Hafner, M.; Landthaler, M.; Burger, L.; Khorshid, M.; Hausser, J.; Berninger, P.; Rothballer, A.; Ascano, M. Jr.; Jungkamp, A.C.; Munschauer, M.; et al. Transcriptome-wide identification of RNA-binding protein and microRNA target sites by PAR-CLIP. Cell 2010, 141, 129-141.
52. Chi, S.W.; Zang, J.B.; Mele, A.; Darnell, R.B. Argonaute HITS-CLIP decodes microRNA-mRNA interaction maps. Nature 2009, 460, 479-486.
53. Wang, W.X.; Wilfred, B.R.; Hu, Y.; Stromberg, A.J.; Nelson, P.T. Anti-Argonaute RIP-Chip shows that miRNA transfections alter global patterns of mRNA recruitment to microribonucleoprotein complexes. RNA 2010, 16, 394-404.
54. Wang, W.X.; Wilfred, B.R.; Xie, K.; Jennings, M.H.; Hu, Y.H.; Stromberg, A.J.; Nelson, P.T. Individual microRNAs (miRNAs) display distinct mRNA targeting "rules". RNA Biol. 2010, 7, 373-380.
55. Matkovich, S.J.; Van Booven, D.J.; Eschenbacher, W.H.; Dorn, G.W., 2nd. RISC RNA sequencing for context-specific identification of in vivo microRNA targets. Circ. Res. 2011, 108, 18-26.
56. Boudreau, R.L.; Jiang, P.; Gilmore, B.L.; Spengler, R.M.; Tirabassi, R.; Nelson, J.A.; Ross, C.A.; Xing, Y.; Davidson, B.L. Transcriptome-wide discovery of microRNA binding sites in human brain. Neuron 2014, 81, 294-305.
57. Tattikota, S.G.; Rathjen, T.; McAnulty, S.J.; Wessels, H.H.; Akerman, I.; van de Bunt, M.; Hausser, J.; Esguerra, J.L.; Musahl, A.; Pandey, A.K.; et al. Argonaute2 Mediates Compensatory Expansion of the Pancreatic beta Cell. Cell MeTable 2014, 19, 122-134.
58. Karginov, F.V.; Conaco, C.; Xuan, Z.; Schmidt, B.H.; Parker, J.S.; Mandel, G.; Hannon, G.J. A biochemical approach to identifying microRNA targets. Proc. Natl. Acad. Sci. USA 2007, 104, 19291-19296.
59. Helwak, A.; Kudla, G.; Dudnakova, T.; Tollervey, D. Mapping the human miRNA interactome by CLASH reveals frequent noncanonical binding. Cell 2013, 153, 654-665.
60. Fabian, M.R.; Sonenberg, N. The mechanics of miRNA-mediated gene silencing: A look under the hood of miRISC. Nat. Struct. Mol. Biol. 2012, 19, 586-593.
61. Djuranovic, S.; Nahvi, A.; Green, R. miRNA-mediated gene silencing by translational repression followed by mRNA deadenylation and decay. Science 2012, 336, 237-240.
62. Kameswaran, V.; Bramswig, N.C.; McKenna, L.B.; Penn, M.; Schug, J.; Hand, N.J.; Chen, Y.; Choi, I.; Vourekas, A.; Won, K.J.; et al. Epigenetic regulation of the DLK1-MEG3 microRNA cluster in human type 2 diabetic islets. Cell MeTable 2014, 19, 135-145.
63. Burger, K.; Muhl, B.; Kellner, M.; Rohrmoser, M.; Gruber-Eber, A.; Windhager, L.; Friedel, C.C.; Dolken, L.; Eick, D. 4-thiouridine inhibits rRNA synthesis and causes a nucleolar stress response. RNA Biol. 2013, 10.
64. Androsavich, J.R.; Chau, B.N. Non-inhibited miRNAs shape the cellular response to anti-miR. Nucleic Acids Res. 2014. doi: 10.1093/nar/gku344.
65. Kishore, S.; Jaskiewicz, L.; Burger, L.; Hausser, J.; Khorshid, M.; Zavolan, M. A quantitative analysis of CLIP methods for identifying binding sites of RNA-binding proteins. Nat. Methods 2011, 8, 559-564.
66. Zuker, M. Mfold web server for nucleic acid folding and hybridization prediction. Nucleic Acids Res. 2003, 31, 3406-3415.
67. Long, D.; Lee, R.; Williams, P.; Chan, C.Y.; Ambros, V.; Ding, Y. Potent effect of target structure on microRNA function. Nat. Struct. Mol. Biol. 2007, 14, 287-294.
68. Rehmsmeier, M.; Steffen, P.; Hochsmann, M.; Giegerich, R. Fast and effective prediction of microRNA/target duplexes. RNA 2004, 10, 1507-1517.
69. Meijer, H.A.; Kong, Y.W.; Lu, W.T.; Wilczynska, A.; Spriggs, R.V.; Robinson, S.W.; Godfrey, J.D.; Willis, A.E.; Bushell, M. Translational repression and eIF4A2 activity are critical for microRNA-mediated gene regulation. Science 2013, 340, 82-85.
70. Ingolia, N.T.; Brar, G.A.; Rouskin, S.; McGeachy, A.M.; Weissman, J.S. The ribosome profiling strategy for monitoring translation in vivo by deep sequencing of ribosome-protected mRNA fragments. Nat. Protoc. 2012, 7, 1534-1550.
71. Del Prete, M.J.; Vernal, R.; Dolznig, H.; Mullner, E.W.; Garcia-Sanz, J.A. Isolation of polysome-bound mRNA from solid tissues amenable for RT-PCR and profiling experiments. RNA 2007, 13, 414-421.
72. Drawnel, F.M.; Wachten, D.; Molkentin, J.D.; Maillet, M.; Aronsen, J.M.; Swift, F.; Sjaastad, I.; Liu, N.; Catalucci, D.; Mikoshiba, K.; et al. Mutual antagonism between IP(3)RII and miRNA-133a regulates calcium signals and cardiac hypertrophy. J. Cell Biol. 2012, 199, 783-798.
73. Baek, D.; Villen, J.; Shin, C.; Camargo, F.D.; Gygi, S.P.; Bartel, D.P. The impact of microRNAs on protein output. Nature 2008, 455, 64-71.
74. Selbach, M.; Schwanhausser, B.; Thierfelder, N.; Fang, Z.; Khanin, R.; Rajewsky, N. Widespread changes in protein synthesis induced by microRNAs. Nature 2008, 455, 58-63.
75. Mallat, Y.; Tritsch, E.; Ladouce, R.; Winter, D.L.; Friguet, B.; Li, Z.; Mericskay, M. Proteome modulation in H9c2 cardiac cells by microRNAs miR-378 and miR-378*. Mol. Cell. Proteomics 2014, 13, 18-29.
76. Raddatz, K.; Albrecht, D.; Hochgrafe, F.; Hecker, M.; Gotthardt, M. A proteome map of murine heart and skeletal muscle. Proteomics 2008, 8, 1885-1897.
77. Chen, J.F.; Murchison, E.P.; Tang, R.; Callis, T.E.; Tatsuguchi, M.; Deng, Z.; Rojas, M.; Hammond, S.M.; Schneider, M.D.; Selzman, C.H.; et al. Targeted deletion of Dicer in the heart leads to dilated cardiomyopathy and heart failure. Proc. Natl. Acad. Sci. USA 2008, 105, 2111-2116.
78. Carrer, M.; Liu, N.; Grueter, C.E.; Williams, A.H.; Frisard, M.I.; Hulver, M.W.; Bassel-Duby, R.; Olson, E.N. Control of mitochondrial metabolism and systemic energy homeostasis by microRNAs 378 and 378*. Proc. Natl. Acad. Sci. USA 2012, 109, 15330-15335.
79. Ganesan, J.; Ramanujam, D.; Sassi, Y.; Ahles, A.; Jentzsch, C.; Werfel, S.; Leierseder, S.; Loyer, X.; Giacca, M.; Zentilin, L.; et al. MiR-378 controls cardiac hypertrophy by combined repression of mitogen-activated protein kinase pathway factors. Circulation 2013, 127, 2097-2106.
80. Mendell, J.T.; Olson, E.N. MicroRNAs in stress signaling and human disease. Cell 2012, 148, 1172-1187.
81. Martin, M.M.; Buckenberger, J.A.; Jiang, J.; Malana, G.E.; Nuovo, G.J.; Chotani, M.; Feldman, D.S.; Schmittgen, T.D.; Elton, T.S. The human angiotensin II type 1 receptor +1166 A/C polymorphism attenuates microRNA-155 binding. J. Biol. Chem. 2007, 282, 24262-24269.
82. Seok, H.Y.; Chen, J.; Kataoka, M.; Huang, Z.P.; Ding, J.; Yan, J.; Hu, X.; Wang, D.Z. Loss of microRNA-155 protects the heart from pathological cardiac hypertrophy. Circ. Res. 2014, 114, 1585-1595.
83. Kallen, A.N.; Zhou, X.B.; Xu, J.; Qiao, C.; Ma, J.; Yan, L.; Lu, L.; Liu, C.; Yi, J.S.; Zhang, H.; et al. The imprinted H19 lncRNA antagonizes let-7 microRNAs. Mol. Cell 2013, 52, 101-112.
84. Tay, Y.; Rinn, J.; Pandolfi, P.P. The multilayered complexity of ceRNA crosstalk and competition. Nature 2014, 505, 344-352.
85. Denzler, R.; Agarwal, V.; Stefano, J.; Bartel, D.P.; Stoffel, M. Assessing the ceRNA hypothesis with quantitative measurements of miRNA and target abundance. Mol. Cell 2014, 54, 766-776.
86. Subramanian, A.; Tamayo, P.; Mootha, V.K.; Mukherjee, S.; Ebert, B.L.; Gillette, M.A.; Paulovich, A.; Pomeroy, S.L.; Golub, T.R.; Lander, E.S.; et al. Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl. Acad. Sci. USA 2005, 102, 15545-15550.
87. Broad_Institute GSEA. Available on line: http://www.broadinstitute.org/gsea/index.jsp (accessed on 18 July 2014)
88. Huang da, W.; Sherman, B.T.; Lempicki, R.A. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat. Protoc. 2009, 4, 44-57.
89. Thomson_Reuters MetaCore. Available on line: http://www.genego.com (accessed on 18 July 2014).
90. Gurha, P.; Wang, T.; Larimore, A.H.; Sassi, Y.; Abreu-Goodger, C.; Ramirez, M.O.; Reddy, A.K.; Engelhardt, S.; Taffet, G.E.; Wehrens, X.H.; et al. microRNA-22 promotes heart failure through coordinate suppression of PPAR/ERR-nuclear hormone receptor transcription. PLoS One 2013, 8, e75882.
91. Terentyev, D.; Belevych, A.E.; Terentyeva, R.; Martin, M.M.; Malana, G.E.; Kuhn, D.E.; Abdellatif, M.; Feldman, D.S.; Elton, T.S.; Gyorke, S. miR-1 overexpression enhances Ca(2+) release and promotes cardiac arrhythmogenesis by targeting PP2A regulatory subunit B56alpha and causing CaMKII-dependent hyperphosphorylation of RyR2. Circ. Res. 2009, 104, 514-521.
92. Abdi, A.; Tahoori, M.B.; Emamian, E.S. Fault diagnosis engineering of digital circuits can identify vulnerable molecules in complex cellular pathways. Sci. Signal 2008, 1, ra10.
93. Ryall, K.A.; Holland, D.O.; Delaney, K.A.; Kraeutler, M.J.; Parker, A.J.; Saucerman, J.J. Network reconstruction and systems analysis of cardiac myocyte hypertrophy signaling. J. Biol. Chem. 2012, 287, 42259-42268.
94. Van Rooij, E.; Purcell, A.L.; Levin, A.A. Developing microRNA therapeutics. Circ. Res. 2012, 110, 496-507.
95. Krutzfeldt, J.; Rajewsky, N.; Braich, R.; Rajeev, K.G.; Tuschl, T.; Manoharan, M.; Stoffel, M. Silencing of microRNAs in vivo with "antagomirs". Nature 2005, 438, 685-689.
96. Thum, T.; Gross, C.; Fiedler, J.; Fischer, T.; Kissler, S.; Bussen, M.; Galuppo, P.; Just, S.; Rottbauer, W.; Frantz, S.; et al. MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts. Nature 2008, 456, 980-984.
97. Montgomery, R.L.; Hullinger, T.G.; Semus, H.M.; Dickinson, B.A.; Seto, A.G.; Lynch, J.M.; Stack, C.; Latimer, P.A.; Olson, E.N.; van Rooij, E. Therapeutic inhibition of miR-208a improves cardiac function and survival during heart failure. Circulation 2011, 124, 1537-1547.
98. Bernardo, B.C.; Gao, X.M.; Winbanks, C.E.; Boey, E.J.; Tham, Y.K.; Kiriazis, H.; Gregorevic, P.; Obad, S.; Kauppinen, S.; Du, X.J.; et al. Therapeutic inhibition of the miR-34 family attenuates pathological cardiac remodeling and improves heart function. Proc. Natl. Acad. Sci. USA 2012, 109, 17615-17620.
99. Ucar, A.; Gupta, S.K.; Fiedler, J.; Erikci, E.; Kardasinski, M.; Batkai, S.; Dangwal, S.; Kumarswamy, R.; Bang, C.; Holzmann, A.; et al. The miRNA-212/132 family regulates both cardiac hypertrophy and cardiomyocyte autophagy. Nat. Commun. 2012, 3, 1078.
100. Boon, R.A.; Iekushi, K.; Lechner, S.; Seeger, T.; Fischer, A.; Heydt, S.; Kaluza, D.; Treguer, K.; Carmona, G.; Bonauer, A.; et al. MicroRNA-34a regulates cardiac ageing and function. Nature 2013, 495, 107-110.
101. Li, R.C.; Tao, J.; Guo, Y.B.; Wu, H.D.; Liu, R.F.; Bai, Y.; Lv, Z.Z.; Luo, G.Z.; Li, L.L.; Wang, M.; et al. In vivo suppression of microRNA-24 prevents the transition toward decompensated hypertrophy in aortic-constricted mice. Circ. Res. 2013, 112, 601-605.
102. Thum, T.; Chau, N.; Bhat, B.; Gupta, S.K.; Linsley, P.S.; Bauersachs, J.; Engelhardt, S. Comparison of different miR-21 inhibitor chemistries in a cardiac disease model. J. Clin. Invest. 2011, 121, 461-462.
103. Patrick, D.M.; Kauppinen, S.; van Rooij, E.; Olson, E.N. Response to Thum; et al. J. Clin. Invest. 2011, 121, 462-463.
104. Janssen, H.L.; Reesink, H.W.; Lawitz, E.J.; Zeuzem, S.; Rodriguez-Torres, M.; Patel, K.; Van der Meer, A.J.; Patick, A.K.; Chen, A.; Zhou, Y.; et al. Treatment of HCV infection by targeting microRNA. N. Engl. J. Med. 2013, 368, 1685-1694.
105. Bouchie, A. First microRNA mimic enters clinic. Nat. Biotechnol. 2013, 31, 577.
106. Grueter, C.E.; Van Rooij, E.; Johnson, B.A.; DeLeon, S.M.; Sutherland, L.B.; Qi, X.; Gautron, L.; Elmquist, J.K.; Bassel-Duby, R.; Olson, E.N. A cardiac microRNA governs systemic energy homeostasis by regulation of MED13. Cell 2012, 149, 671-683.